We are very excited to announce a major news to all our supporters:
On 1st May, the Editorial Office received the pleasant news from Scopus Title Evaluation Support that Journal of Cancer Metastasis and Treatment (JCMT, ISSN 2454-2857 (Online), ISSN 2394-4722 (Print)) had been indexed in Scopus database after rigorously evaluated by the Content Selection & Advisory Board (CSAB). Not just for JCMT, but also for OAE, this is a great breakthrough in the course of publishing development. The Editorial Office would like to express sincere gratitude to all Editorial Board members, guest editors, authors, readers, reviewers and all of those contributing to JCMT.
As mentioned in the official email, this is clearly primarily a Chinese-based journal and publisher with a US office. The journal is publishing around 55 items per annum, including some with a basis in herbal and complementary medicine. It exhibits reasonable citation activity. The subject matter is important and the content is relatively fresh. It's well-known that Scopus is the biggest abstract and citation database in the world, which covers the natural sciences, technology, engineering, medicine and social sciences, arts, humanities and many other disciplines. CiteScore, the evaluated indicator of Scopus, is regarded as the strongest competitor for the Impact Factor. The high recognition and praise of JCMT from Scopus will encourage it to continue to adhere to the principle of high-quality publication, explore innovative academic topics and make every effort to publish valuable academic findings for promoting the innovation and development of scientific research. We firmly believe that in the near future, JCMT will become a leading journal in the related field.